Clik here to view.
Pharmaron and MSD Agree Deal to Acquire MSD’s UK Hoddesdon Site
BEIJING Pharmaron has entered into a non-binding Heads of Terms (HoTs) with Merck Sharpe & Dohme Limited (MSD) for the sale of the Hoddesdon UK site which includes MSD’s process development and...
View ArticleClik here to view.
SAB Biotherapeuticsの免疫療法に関する提案がWHO報告書で優秀なプラットフォーム技術ソリューションの1つに選ばれる
米メリーランド州ベセスダ & 米サウスダコタ州スーフォールズ （ビジネスワイヤ） — 臨床段階のバイオ医薬品開発企業SAB Biotherapeutics（SAB）は本日、染色体導入ウシ（Tc...
View ArticleClik here to view.
Exelixis Announces Collaborator Daiichi Sankyo’s Initiation of Phase 3...
SOUTH SAN FRANCISCO, Calif. Exelixis, Inc. (NASDAQ:EXEL) today announced that its partner Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) has initiated a phase 3 pivotal trial to...
View ArticleClik here to view.
ジャイロス・プロテイン・テクノロジーズ、日本に専用オフィスを設立
スウェーデン・ウプサラ （ビジネスワイヤ） — ナノリットルスケール・イムノアッセイ装置自動化の先駆者であり、ペプチドシンセサイザーおよびペプチド試薬のリーディングプロバイダーであるジャイロス・プロテイン・テクノロジーズは本日、日本の東京に専用オフィスを開設し、ジャイロス・ジャパン株式会社を設立したと発表しました。...
View ArticleClik here to view.
First Patient Dosed in CANbridge’s CAN-008 Phase I/II Trial in...
BEIJING CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that the first patient was dosed in the Phase I/II trial...
View ArticleClik here to view.
Clik here to view.
武田薬品とアフィロジックが研究提携契約を締結し、Nanofitin®を使用して中枢神経系疾患の治療薬開発に当たる
大阪 & 仏ナント — （ビジネスワイヤ） — 武田薬品工業株式会社（TSE:...
View ArticleClik here to view.
New Standards for Forensic Grade Manufacturing Integrated At Promega
MADISON, Wis. With recent approval in meeting the new ISO 18385 standard, Promega Corporation will be including a “Forensic Grade” classification on products used for human identity by crime labs,...
View ArticleClik here to view.
Gilead Sciences and the World Health Organization Announce Five-Year Visceral...
FOSTER CITY, Calif. Gilead Sciences, Inc. (Nasdaq:GILD) today announced it has entered into a partnership with the World Health Organization (WHO) to provide $20 million in funding and drug...
View ArticleClik here to view.
ARIAD Announces Regulatory Approval for Iclusig® (ponatinib) in Japan
CAMBRIDGE, Mass. ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that its partner Otsuka Pharmaceutical Co., Ltd. (Otsuka) has received approval from the Japanese Pharmaceuticals and...
View ArticleClik here to view.
MSD Animal Health Demonstrates Commitment to Eliminate Rabies Worldwide with...
MADISON, N.J. MSD Animal Health (known as Merck Animal Health in the United States and Canada) is proud to announce a landmark accomplishment in its fight against rabies with the donation of now...
View ArticleClik here to view.
Zymeworks and Daiichi Sankyo Announce Immuno-Oncology Cross-Licensing...
VANCOUVER, British Columbia & TOKYO & PARSIPPANY, N.J. Zymeworks Inc., a clinical-stage biopharmaceutical company discovering and developing innovative multi-functional protein-based...
View ArticleClik here to view.
默沙东动物保健部捐赠的疫苗迄今已超过200万头份，彰显对根除全球狂犬病的承诺
新泽西州麦迪逊 (美国商业资讯) — 默沙东动物保健部(MSD Animal Health)（在美国和加拿大称为默克动物保健部）自豪地宣布了其抗击狂犬病的一项里程碑成就，即向从事根除这一完全可预防疾病的组织捐赠的宠必威®(NOBIVAC®)狂犬病疫苗现已超过200万头份。今年通过Afya塞伦盖蒂计划和Mission...
View ArticleClik here to view.
Shiseido Names Claudia Poccia Chief Marketing Officer of Bare Escentuals
NEW YORK Shiseido Americas Corporation (“Shiseido Americas”), a subsidiary of Tokyo-based, global cosmetics company Shiseido Company, Limited (“Shiseido”), today announced that Claudia Poccia has...
View ArticleClik here to view.
Agilent Technologies and Burning Rock Sign Agreement on Molecular Diagnostics
SANTA CLARA, Calif. & GUANGZHOU, China Agilent Technologies Inc. (NYSE:A) and Burning Rock today announced they have signed an agreement under which Burning Rock will develop cancer diagnostics...
View ArticleClik here to view.
22ndセンチュリーの超低ニコチン禁煙製品「X-22」が圧倒的多数の医師と消費者から支持されたことが報告
米ニューヨーク州クラレンス （ビジネスワイヤ） — タバコの有害性低減でリードする植物バイオテクノロジー企業の22ndセンチュリー・グループ（NYSE MKT:XXII）は、2件の独立調査から得られた結果を発表しました。これらの結果は、消費者からの強い需要が、当社において開発中の禁煙補助製品X-22を処方したいという医師の意思に反映されていることを示しています。...
View ArticleClik here to view.
Alzheon to Present at Upcoming Asian Healthcare and Scientific Conferences
FRAMINGHAM, Mass. Alzheon Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease and other neurological and psychiatric...
View ArticleClik here to view.
Acelity Announces Expiration of and Final Results for the Exchange Offer with...
SAN ANTONIO Acelity L.P. Inc. (“Acelity”), a global advanced wound care and regenerative medicine company, today announced the final results of the private offer to Eligible Holders (as defined...
View ArticleClik here to view.
カーディナル・ヘルスがアジア事業を拡大
香港 （ビジネスワイヤ） — 総合的なヘルスケアサービス／製品を提供する世界一流企業のカーディナル・ヘルス（NYSE:CAH）は本日、アジア事業拡大の一環として、当社パウダーフリー手袋の製品ラインを香港に投入すると同時に、使い捨てドレープ／ガウンの分野へ一層浸透していくと発表しました。...
View ArticleClik here to view.
Cardinal Health Expands in Asia
HONG KONG Leading global, integrated healthcare services and products company, Cardinal Health (NYSE:CAH), today announced that it will bring its powder-free gloves product line to Hong Kong while...
View Article